{"disease":{"id":"untreated-human-epidermal-growth-factor-receptor-2-her2-positive-early-breast-cancer","name":"untreated human epidermal growth factor receptor 2 her2 positive early breast cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01834950","title":"Identification of Early Markers of Response and Resistance to Trastuzumab","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}